- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Valion Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 03.06. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work | 2 | Seeking Alpha | ||
| 14.05. | Valion Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio subsidiary secures exclusive NMR platform license | 1 | Investing.com | ||
| 14.05. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial Results | 170 | PR Newswire | First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity... ► Artikel lesen | |
| 05.05. | Valion Bio receives protocol for radiation syndrome drug study | 3 | Investing.com | ||
| VALION BIO Aktie jetzt für 0€ handeln | |||||
| 05.05. | Tivic Health Systems, Inc.: Valion Bio Receives First FDA-precedent Study Protocol From Niaid For Entolimod; Federal Agency To Fully Fund Bla-enabling In Vivo Program And Co-navigate FDA Submission | 171 | PR Newswire | Initial Study to Evaluate Entolimod for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome - an Indication for Which No Currently Approved... ► Artikel lesen | |
| 04.05. | Valion Bio, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.04. | Tivic Health Systems Rebrands to Valion Bio | 2 | Contract Pharma | ||
| 24.04. | Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening | 2 | Benzinga.com | ||
| 23.04. | Tivic Health Systems, Inc.: Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model | 213 | PR Newswire | Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod Toward BARDA Funding and Strategic National Stockpile Procurement... ► Artikel lesen | |
| 23.04. | Tivic Health Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 31.03. | Tivic Health receives Ukraine request for radiation treatment | 6 | Investing.com | ||
| 31.03. | Tivic Health Systems: Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod | 373 | ACCESS Newswire | SAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company, today announced it has received a formal Request for Information... ► Artikel lesen | |
| 27.03. | Tivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference | 656 | ACCESS Newswire | Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID SAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage... ► Artikel lesen | |
| 26.03. | Tivic Health Systems: Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome | 545 | ACCESS Newswire | Armed Forces Radiobiology Research Institute (AFRRI) Will Conduct the Gastrointestinal Acute Radiation Syndrome (GI-ARS) Study SAN ANTONIO, TX / ACCESS Newswire / March 26, 2026 / Tivic Health Systems... ► Artikel lesen | |
| 26.03. | Tivic Health Systems reports FY25 results | 2 | Seeking Alpha |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,575 | -1,93 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| ORGANON | 11,565 | -0,22 % | FDA erweitert Indikationen für Tocilizumab-Biosimilar von Organon | ||
| CO-DIAGNOSTICS | 4,840 | -0,82 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| SENSEONICS | 6,650 | +4,72 % | Senseonics, Welldoc partner on next-gen Eversense 365 app development | ||
| VIRIDIAN THERAPEUTICS | 14,200 | +3,65 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,000 | +1,09 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| VYOME | 2,170 | +0,46 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| AXOGEN | 35,500 | +0,51 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| EMBECTA | 2,756 | -1,36 % | Dividendenbekanntmachungen (28.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACTIVIA PROPERTIES INC JP3047490002 3169 JPY 17,0809 EUR ADVANCED MEDICAL SOLUTIONS GROUP PLC GB0004536594 0,0201 GBP 0,0232 EUR AIA... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,100 | +0,03 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| TACTILE SYSTEMS TECHNOLOGY | 22,320 | -0,89 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 4,240 | +5,47 % | Der durch STRC besicherte Stablecoin von Apyx erleidet eine kurze Entkopplung. Das Protokoll bezeichnet dies als Funktion, nicht als Fehler | ||
| GLAUKOS | 105,00 | -1,87 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,688 | +4,82 % | Lexaria Bioscience Corp.: Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway | Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary DehydraTECH KELOWNA, BC / ACCESS Newswire / June 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria"... ► Artikel lesen | |
| PICARD MEDICAL | 0,205 | -1,49 % | PICARD MEDICAL, INC. Issues Letter to Shareholders | TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and... ► Artikel lesen |
VALION BIO INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,90 % bei einem Aktienkurs von 0,790 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VALION BIO INC finden Sie auf Wallstreet Online.